(Q74290988)

English

Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. UK Multicenter Study Group

scientific article published on 01 December 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. UK Multicenter Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

361-366

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study--final results

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

A retrospective study of 932 second trimester terminations using gemeprost (16, 16 dimethyl-trans Δ2 PGE1 methyl ester)

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Mid-trimester termination of pregnancy with 16,16-dimethyl-trans-Δ2PGE1vaginal pessaries: A comparison with intra- and extra-amniotic prostaglandin E2administration

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Termination of second trimester pregnancy with laminaria and intramuscular 15-methyl PGF2 alpha or 16-phenoxy-omega-17,18,19,20-tetranor PGE2 methyl sulfonylamide. A randomized multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

The effect of epostane, a 3-beta hydroxy steroid dehydrogenase inhibitor, on maternal and fetal steroid levels during mid-gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Mifepristone for labour induction after previous caesarean section

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Prostaglandin-induced pregnancy termination: further studies using gemeprost (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) vaginal pessaries in the early second trimester

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Dilatation and curettage for second-trimester abortions

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900184-4

7 January 2021

Identifiers

10.1016/S0010-7824(97)00184-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9494769%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74290988&oldid=2084548563"